1/95
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Biopharmaceuticals are pharmaceutical drug products that are manufactured in or extracted from or semi-synthesized from ______________ sources using cutting-edge _______________________ methods
biological, biotechnological
What is biopharmaceuticals also called?
biologics
Biopharmaceuticals are ___________ _____________ molecules made with the help of ____________ cells
complex larger, living
Biopharmaceuticals are complex larger molecules made with the help of living cells, such as what?
bacteria, yeast, animal or plant cells
Unlike smaller molecules that are given to a patient through tablets, the large molecules (biopharmaceuticals) are typically _______________ into the patient's body
injected
What "project" led to the development of protein drugs?
the human genome project
In order for protein drugs to function properly and be effective, the structure of the _____________ has to be maintained
protein
What kind of technology allows us to produce protein drugs?
recombinant DNA technology
Before recombinant DNA technology, protein drugs were derived from what sources?
humans and animals
What are examples of protein drugs?
rHuman insulin (Humulin), rhuman growth hormone (protropin), recombinant interferons, interleukins
Recombinant DNA technologies involve ______________ modification of organisms
genetic
Recombinant DNA technology: Genetic modification of organisms is done by fusion of any _______ _______________ to _______ _______________ that are able to maintain themselves by autonomous ___________________
DNA fragment, DNA molecule (plasmid), replication
Since DNA molecules (plasmids) are able to maintain themselves by autonomous replication, they are also called what?
replicons
Recombinant DNA/DNA Cloning Technology: This involves fusing ____________ DNA fragments to the isolated ______________ in order to create a ________________ ________ molecule
foreign, plasmid, recombinant DNA
Recombinant DNA/DNA Cloning Technology: Once the foreign DNA is fused into the plasmid, what is the plasmid then called?
a replicon or vector (isnt technically a replicon or recombinant DNA until the foreign DNA is fused into it)
Recombinant DNA/DNA Cloning Technology: What is foreign DNA (DNA that is inserted into plasmids) isolated from?
microbial, plant or animal cells
Recombinant DNA/DNA Cloning Technology: What enzyme is used to cut DNA at specific sites on both the foreign DNA and plasmid?
restriction enzyme
Recombinant DNA/DNA Cloning Technology: What enzyme is used to close the circular recombinant DNA (the plasmid with the foreign DNA inserted into it)
ligase enzyme
Recombinant DNA/DNA Cloning Technology: Once the recombinant DNA (foreign DNA inserted into plasmid) is introduced into the host cell, what is the host cell called?
transformant (transformant = host cell that contains recombinant DNA)
Recombinant DNA/DNA Cloning Technology: Vectors (replicons) __________________ inside of the host cell
replicate
Recombinant DNA/DNA Cloning Technology: Vectors replicate inside of the host cell, thus all ________________ cells in the host cell will inherit a precise copy (a clone) of the ______________________ _______ molecule
daughter, recombinant DNA
Monoclonal Antibodies are _____-shaped
Y
Monoclonal antibodies contain an _____________ binding site
antigen
The antigen binding site on the monoclonal antibody is also called what?
paratope
The antigen binding site on monoclonal antibodies binds to the _______________ on the _____________
epitope, antigen
Monoclonal antibodies bind to antigens via a _________ and _______ mechanism
lock, key
What is considered the "lock" involving monoclonal antibodies binding to antigens?
the antigen binding site on the monoclonal antibody (paratope)
What is considered the "key" involving monoclonal antibodies binding to antigens?
the epitope on the antigen (what the antigen binding site of the monoclonal antibody binds to)
Monoclonal antibodies are highly ______________ to antigens
specific
What two things conjugate together in order to form an antigen?
haptens and proteins
What two "regions" does a monoclonal antibody consist of?
constant (Fc) region and variable region
What is the overall structure of an antibody?
antigen binding fragment, antibody crystallizable region, heavy chains, light chains, variable regions, hinge regions
What is the abbreviation for antigen-binding fragment?
Fab
What is the antibody crystallizable region also known as?
Fc region or constant region
Monoclonal antibodies are typically made by fusing ____________ cells with ______ cells in the _____________ from a mouse that has been _______________ with the desired _______________
myeloma, B, spleen, immunized, antigen
Monoclonal Antibody Production: Once the mouse is immunized with the desired antigen, the mouse's immune system produces _______ cells that accumulate in the spleen
B
Monoclonal Antibody Production: Once the B cells fuse with myeloma cells, what forms?
a hybridoma
Monoclonal Antibody Production: The B cells part of the hybridoma is responsible for what?
producing monoclonal antibodies (antibodies specific to target antigen)
Monoclonal Antibody Production: The myeloma cell part of the hybridoma is reponsible for what?
replication
What are the different type of applications of monoclonal antibodies?
cancer treatment, imaging diagnosis, targeted-specific delivery, transplant rejection suppression
Cancer Treatment: Monoclonal antibodies (mAbs) against _______________ and ______________ have been used as treatment with variable results
leukemia, lymphoma
Imaging Diagnosis: mAbs may be used together with _______________ markers to locate and visualize the location and extent of ______________
radioactive, tumors
Targeted-specific delivery: mAbs may be conjugated to __________ or other delivery systems such as _______________ to allow the specific delivery to target sites
drugs, liposomes
Transplant rejection suppression: In ___________ transplants, there is a mAb that destroys ________, a membrane protein of ____________ ____ cells that causes transplant rejection
kidney, CD3, cytotoxic T
Monoclonal antibodies are named by combining what things?
prefix, antibody target, antibody source, suffix
What is the usual suffix of mAbs?
mab
What are the different types of antibody targets?
bone, cardiovascular, immune-modulating, interleukin, tumor, virus
For mAbs that target bone, what letters are in their name?
o(s)
For mAbs that target cardiovascular, what letters are in their name?
c(i)
For mAbs that are immune-modulating, what letters are in their name?
l(i)
For mAbs that target interleukins, what letters are in their name?
k(i)
For mAbs that target tumors, what letters are in their name?
t(u)
For mAbs that target viruses, what letters are in their name?
v(i)
For mAbs that are derived from humans, what letters are in their name?
u
For mAbs that are humanized, what letters are in their name?
zu
For mAbs that are chimeric, what letters are in their name?
xi
For mAbs that are derived from rats, what letters are in their name?
a
Gene therapy involves the delivery of a ________________ __________ to _________________ cells in the body to produce a ___________________ that corrects defective _______________ function
recombinant gene (DNA), somatic, protein, biologic
Gene therapy focuses on what kind of gene defects?
single-gene defects
What are examples of single gene defects?
CF, hemophilia, muscular dystrophy, thalassemia, sickle cell anemia
Cystic fibrosis gene therapy involves restoring _________________ _____________, which overall improves ________ expectancy of CF patients
chloride channels, life
Gene therapy involves ___________ and ___________ delivery of recombinant DNA (rDNA)
in-vivo, ex-vivo
Gene Therapy: What are examples of recombinant DNA delivery?
virus-based approach, plasmid vector approach
Gene Therapy: The Virus-based approach involves viruses being used as ______________ in order to transport the therapeutic gene into host cells
vector
Virus-based Approach - Gene Therapy: The gene that codes for the ___________ _____________ is inserted into a __________ or __________ virus
therapeutic protein, RNA, DNA
Virus-based Approach - Gene Therapy: The gene that codes for the therapeutic protein (that is inserted into the virus) is also called what?
transgene
Virus-based Approach - Gene Therapy: What are RNA viruses also called?
retroviruses
Virus-based Approach - Gene Therapy: DNA viruses are outside of ___________________
chromosomes
Virus-based Approach - Gene Therapy: What is an example of a type of DNA virus?
adeno-associated virus (AAV)
Virus-based Approach - Gene Therapy: Do viruses replicate?
no (so if the virus is used as a vector it cannot replicate. normal vectors that arent viruses CAN replicate)
Gene Therapy: The plasmid vector approach is non-__________
viral (not a virus)
Gene Therapy: Ex-vivo delivery of rDNA has less _____________ ________________
systemic toxicity
Gene Therapy: What does CAR T cell stand for?
chimeric antigen receptor T cell
Gene Therapy: Chimeric antigen receptors (CARs) are receptor proteins that have been engineered to give T cells the new ability to do what?
target a specific antigen
Gene Therapy: Chimeric antigen receptors (CARs) are chimeric in that they combine both ______________-_____________ and ____ ________ activating functions into a single receptor
antigen-binding, T cell (the CAR is chimeric because it has two functions in one - allows the T cell to bind to antigens and also activates the T cell)
Gene Therapy: What are examples of approved gene therapies?
abcema, zynteglo, luxturna, skysona, zolgensma, imlygic
What is an example of a CAR T-cell therapy?
kymriah (for leukemia and lymphoma)
What does ASO drug stand for?
antisense oligonucleotide drug
Antisense oligonucleotide (ASOs) drugs are drugs that seek to do what?
block DNA transcription or RNA translation
ASO drugs block DNA transcription or RNA translation in order to moderate many ______________ processes
disease
ASO drugs target ______________ and __________ _______________
cancer, viral infections
ASO drugs are delivered into the body using ______________ as carriers
liposomes
Pharmacokinetics of Biopharmaceuticals: There is rapid _______________ of biopharmaceuticals
degredation
Pharmacokinetics of Biopharmaceuticals: There is rapid degradation of biopharmaceuticals by endogenous _____________ and _______________
proteases, nucleases
Pharmacokinetics of Biopharmaceuticals: Degradation of biopharmaceuticals by proteases/nucleases causes the biopharmaceutical to have low ________________
stability (limits activity)
Pharmacokinetics of Biopharmaceuticals: _______________ DNA and RNA (in biopharmaceuticals) have a short half life (only few minutes)
unmodified (chemical structure hasn't been altered)
Pharmacokinetics of Biopharmaceuticals: What remedies are used to overcome the rapid degradation and short half life of biopharmaceuticals?
Chemical modifications or bioengineering to increase size and decrease excretion (of the biopharmaceutical)
Pharmacokinetics of Biopharmaceuticals: Due to the large size and limited diffusional transport of biopharmaceuticals, they have a low what?
volume of distribution (Vd)
Pharmacokinetics of Biopharmaceuticals: What are examples of delivery systems that biopharmaceuticals utilize?
conjugates, nanoparticles, liposomes, viral vectors
Pharmacokinetics of Biopharmaceuticals: The PK for transgenes (foreign DNA fragment that is inserted into plasmid) is difficult to measure to due low ________________ given
concentration
Pharmacokinetics of Biopharmaceuticals: Liposomal delivery of biopharmaceuticals tends to reduce _______ and may be cleared by the __________ and ______________
Vd, spleen, liver
Pharmacokinetics of Biopharmaceuticals: Liposome delivery systems are coated with what?
PEG
Pharmacokinetics of Biopharmaceuticals: PEG coating of liposomes is used to evade _____________ detection
phagocyte (coating the liposome with PEG prevents phagocytes from detecting it so it'll last in the body longer)
A Biosimilar Is a biologic (biopharmaceutical) that is highly _____________ to and has no clinically meaningful _____________________ from an existing ________________ medicine
similar, differences, biological
The existing biological medicine that the biosimilar is highly similar to is called what?
reference point
The reference point of a biosimilar is already licensed by the
FDA